These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neonatal exposure to anti-nerve growth factor antibodies affects exploratory behavior of developing mice in the hole board. Calamandrei G; Pennazza S; Ricceri L; Valanzano A Neurotoxicol Teratol; 1996; 18(2):141-6. PubMed ID: 8709925 [TBL] [Abstract][Full Text] [Related]
5. Impairment of passive avoidance learning following repeated administrations of antibodies against nerve growth factor in neonatal mice. Ricceri L; Alleva E; Calamandrei G Neuroreport; 1994 Jun; 5(11):1401-4. PubMed ID: 7919209 [TBL] [Abstract][Full Text] [Related]
6. Age-dependent effects of NGF and scopolamine on suckling behavior of neonatal mice. Calamandrei G; Valanzano A Pharmacol Biochem Behav; 1994 Dec; 49(4):1043-8. PubMed ID: 7886073 [TBL] [Abstract][Full Text] [Related]
7. Postnatal cocaine exposure affects neonatal passive avoidance performance and cholinergic development in rats. Ricceri L; Tirassa P; Aloe L; Alleva E Pharmacol Biochem Behav; 1993 Jun; 45(2):283-9. PubMed ID: 8327535 [TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Dixon CE; Flinn P; Bao J; Venya R; Hayes RL Exp Neurol; 1997 Aug; 146(2):479-90. PubMed ID: 9270059 [TBL] [Abstract][Full Text] [Related]
9. Different effects of postnatal day 1 versus 7 192 immunoglobulin G-saporin lesions on learning, exploratory behaviors, and neurochemistry in juvenile rats. Ricceri L; Calamandrei G; Berger-Sweeney J Behav Neurosci; 1997 Dec; 111(6):1292-302. PubMed ID: 9438798 [TBL] [Abstract][Full Text] [Related]
10. Oral administration of propentofylline, a stimulator of nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into the rat septum. Nitta A; Ogihara Y; Onishi J; Hasegawa T; Furukawa S; Nabeshima T Behav Brain Res; 1997 Feb; 83(1-2):201-4. PubMed ID: 9062684 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats. Vantini G; Schiavo N; Di Martino A; Polato P; Triban C; Callegaro L; Toffano G; Leon A Neuron; 1989 Sep; 3(3):267-73. PubMed ID: 2484338 [TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Garofalo L; Cuello AC Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938 [TBL] [Abstract][Full Text] [Related]
18. Development of cholinergic pedunculopontine neurons in vitro: comparison with cholinergic septal cells and response to nerve growth factor, ciliary neuronotrophic factor, and retinoic acid. Knusel B; Hefti F J Neurosci Res; 1988; 21(2-4):365-75. PubMed ID: 3216429 [TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism. Hellweg R; Nitsch R; Hock C; Jaksch M; Hoyer S J Neurosci Res; 1992 Mar; 31(3):479-86. PubMed ID: 1386388 [TBL] [Abstract][Full Text] [Related]
20. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]